Accurate estimates of cognitive and clinical decline rates are essential to the design of clinical trials in Alzheimer’s disease (AD) dementia.
from Dementia Big http://ift.tt/1oywIZC via alcoholic dementia
http://ift.tt/1KGDAyF
Tuesday, February 23, 2016
Longitudinal decline in mild-to-moderate Alzheimer's disease: Analyses of placebo data from clinical trials
http://ift.tt/1KGDAyF
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment